Can regular COVID-19 patients get Trump’s treatments?
If you or a loved one has COVID-19, here’s what to consider before seeking experimental treatments.
Some health experts criticize U.S. mass purchase of licensed virus drug
The U.S. government announced this week that it had an agreement with Gilead Sciences to make the bulk of their production of remdesivir available to Americans for the next three months.
Additional Support Provided By:
